DD
Therapeutic Areas
Epygen Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Pegfilgrastim | Oncology (Neutropenia) | Not Disclosed |
| Bevacizumab | Oncology | Not Disclosed |
| Recombinant Streptokinase | Cardiovascular (Thrombolysis) | Not Disclosed |
| Teriparatide | Osteoporosis | Not Disclosed |
| SARS-CoV-2 Vaccine | COVID-19 Prevention | Not Disclosed |